{
    "Trade/Device Name(s)": [
        "Biophen Low Molecular Weight Heparin (LMWH) Control Plasma",
        "Biophen Low Molecular Weight Heparin (LMWH) Control Low",
        "Biophen Unfractionated Heparin (UFH) Control Plasma",
        "Biophen Heparin Calibrator",
        "Biophen UFH Calibrator"
    ],
    "Submitter Information": "Hyphen BioMed",
    "510(k) Number": "K051472",
    "Predicate Device Reference 510(k) Number(s)": [
        "K030965",
        "K030964",
        "K042941"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGN",
        "GGC",
        "KFF",
        "JIT"
    ],
    "Summary Letter Date": "December 23, 2005",
    "Summary Letter Received Date": "November 8, 2005",
    "Submission Date": "November 3, 2005",
    "Regulation Number(s)": [
        "21CFR864.5425",
        "21CFR862.1150"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies",
        "Calibrator, Secondary"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Low Molecular Weight Heparin",
        "Unfractionated Heparin"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Biophen Heparin 3",
        "Biophen Heparin 6"
    ],
    "Method(s)/Technology(ies)": [
        "Anti-Xa colorimetric assay",
        "Chromogenic assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Biophen LMWH and UFH control plasmas and calibrators for quality control and calibration of heparin measurements using chromogenic anti-Xa assays.",
    "Indications for Use Summary": "For quality control and calibration of Low Molecular Weight Heparin (LMWH) and Unfractionated Heparin (UFH) measurements in plasma using anti-Xa colorimetric assays.",
    "fda_folder": "Hematology"
}